The 2019 European Cystic Fibrosis Conference to be held in Liverpool
ACC Liverpool will be the venue for the European Cystic Fibrosis Conference, to be held in the city for the first time. ACC Liverpool...
#ECFS2018 – Multiple Sclerosis Therapy Boosts Antibiotic’s Ability to Kill Resistant P. aeruginosa S
Combining the approved multiple sclerosis treatment glatiramer acetate with the antibiotic tobramycin improved its ability to kill...
#ECFS2018 – 3 Scientists Win 2018 ‘Young Investigators Awards’ for Innovative CF Research
The European Cystic Fibrosis Society presented three scientists — one Portuguese, one Mexican, and one German — with the organization’s...
#ECFS2018 – AB-PA01, with Antibiotics, Shows Promise in Treating Drug-resistant Lung Infections in C
AmpliPhi Biosciences’ investigative therapy AB-PA01, in combination with antibiotics, shows significant potential to treat multi-drug...
PTI-808
PTI-808 is an experimental therapy being developed by Proteostasis Therapeutics to treat the most common type of cystic fibrosis (CF)...
#ECFS2018 — Hard-to-Treat Infections May Not Impact Survival of CF Patients After Lung Transplant, S
One-year survival after a lung transplant of cystic fibrosis (CF) patients chronically infected with antibiotic-resistant bacteria is...
Scientists work to dissolve the NETs that worsen TBI damage
Immune cells that are first responders to a traumatic brain injury appear to also contribute to the secondary damage that can occur even...
Spyryx SPX-101 Phase 2 HOPE-1 Trial Shows Improvement in Lung Function in Patients with Cystic Fibro
DURHAM, N.C., June 6, 2018 /PRNewswire/ -- Today Spyryx shared positive data for the first cohort of the SPX-101 Phase 2 clinical trial...
Cystic Fibrosis Medications: What You Need to Know
Cystic fibrosis is a life-threatening, genetic disease that affects patients’ ability to breathe and is marked by persistent lung...
Way Found to Use Antimicrobial Peptides, Part of Immune System, to Treat Bacterial Lung and Wound In
Antimicrobial peptides administered as tiny nanoparticles show promise in treating bacterial infections without risking making the...
